Suchergebnisse - "Taneja, Vikas"

PubPharm (24)

1

Safety of Biologic and Small Molecule Therapy for Inflammatory Bowel Disease Among Solid Organ Transplant Recipients : Systematic Review and Meta-Analysis

enthalten in: Inflammatory bowel diseases | 2024

von Taneja, V. | Anand, R. | El-Dallal, M. | +4

2

WITHDRAWN : Non-Anti-TNF Biologics as Salvage Therapy for Refractory Acute Severe Ulcerative Colitis, A Systematic Review

enthalten in: Current reviews in clinical and experimental pharmacology | 2023

von Weissman, S. | Aziz, M. | Bangolo, A. | +25

3

Effectiveness and Safety of Tofacitinib for Ulcerative Colitis : Systematic Review and Meta-analysis

enthalten in: Journal of clinical gastroenterology | 2022

von Taneja, V. | El-Dallal, M. | Haq, Z. | +7

CommentIn: J Clin Gastroenterol. 2023 Apr 01;57(4):429. - PMID 36728526

4

Efficacy and safety of biologic therapy in microscopic colitis : systematic review and meta-analysis

enthalten in: European journal of gastroenterology & hepatology | 2022

von Taneja, V. | El-Dallal, M. | Anand, R. | +3

5

Impact of Cirrhosis on Outcomes in Inflammatory Bowel Disease Hospitalizations

enthalten in: Journal of clinical gastroenterology | 2022

von Taneja, V. | Stein, D. | Feuerstein, J.

6

Quality measures in endoscopy : A systematic analysis of the overall scientific level of evidence and conflicts of interest

enthalten in: Endoscopy international open | 2022

von Weissman, S. | Aziz, M. | Baniqued, M. | +5

7

Excipient Hypersensitivity Masquerading as Multidrug Allergy

enthalten in: The American journal of medicine | 2021

von Taneja, V. | Taneja, I. | Mihali, A. | +1

8

Patient Perspective on Safety of Elective Gastrointestinal Endoscopy During the COVID-19 Pandemic

enthalten in: Techniques and innovations in gastrointestinal endoscopy | 2021

von Taneja, V. | El-Dallal, M. | Bilal, M. | +7

ErratumIn: Tech Innov Gastrointest Endosc. 2022;24(2):219-220. - PMID 35308800

9

Letter to the Editor : Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease

enthalten in: Hepatology (Baltimore, Md.) | 2020

von Taneja, V.

CommentOn: Hepatology. 2019 Jun;69(6):2414-2426. - PMID 30341767

10

Letter to the Editor : Intrahepatic Lipid Content After Insulin Glargine Addition to Metformin in Type II Diabetes Mellitus With Nonalcoholic Fatty Liver Disease

enthalten in: Hepatology | 2020

von Taneja, V.